Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.
暂无分享,去创建一个
K. Mechtler | F. Szoka | E. Wagner | C. Plank
[1] M. Hashida,et al. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. , 1995, Journal of pharmaceutical sciences.
[2] D. Liggitt,et al. Cationic Liposome-mediated Intravenous Gene Delivery (*) , 1995, The Journal of Biological Chemistry.
[3] C. Y. Chow,et al. A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. , 1995, Biochemistry.
[4] L. Mahan,et al. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Miller,et al. Gene delivery and expression mediated by an integrin-binding peptide. , 1995, Gene therapy.
[6] S. Varsano,et al. Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract. , 1995, American journal of respiratory and critical care medicine.
[7] D. Scherman,et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[8] K. Rice,et al. Targeted gene delivery with a low molecular weight glycopeptide carrier. , 1995, Bioconjugate chemistry.
[9] I. Wicks,et al. Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy. , 1995, Human gene therapy.
[10] J. C. Perales,et al. Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. , 1995, The Journal of clinical investigation.
[11] C. Wu,et al. Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. , 1994, Human gene therapy.
[12] J. Behr,et al. Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. , 1994, Bioconjugate chemistry.
[13] B. Meyrick,et al. No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. , 1994, Journal of applied physiology.
[14] M. Cotten,et al. Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. , 1994, Gene therapy.
[15] J. Wilson,et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. , 1994, The Journal of biological chemistry.
[16] J. C. Perales,et al. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] Matthew Cotten,et al. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis , 1994 .
[18] B. Meyrick,et al. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. , 1994, The Journal of clinical investigation.
[19] M. Cotten,et al. Non-viral approaches to gene therapy. , 1993, Current opinion in biotechnology.
[20] Catherine H. Wu,et al. Liver-directed gene delivery , 1993 .
[21] P. Davis,et al. Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. , 1993, The Journal of clinical investigation.
[22] C. Alving,et al. Complement-dependent phagocytosis of liposomes. , 1993, Chemistry and physics of lipids.
[23] F. Szoka,et al. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. , 1993, Bioconjugate chemistry.
[24] S. Tomlinson. Complement defense mechanisms. , 1993, Current opinion in immunology.
[25] H. Gewurz,et al. DNA binds and activates complement via residues 14-26 of the human C1q A chain. , 1992, The Journal of biological chemistry.
[26] M. Woodle,et al. Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.
[27] S. Thorgeirsson,et al. Adenovirus–mediated in vivo gene transfer and expression in normal rat liver , 1992, Nature Genetics.
[28] J H Senior,et al. Interaction of positively-charged liposomes with blood: implications for their application in vivo. , 1991, Biochimica et biophysica acta.
[29] M. Cotten,et al. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Wilson,et al. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. , 1991, The Journal of biological chemistry.
[31] K. Mechtler,et al. DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. , 1991, Bioconjugate chemistry.
[32] D. Devine,et al. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. , 1991, Journal of immunology.
[33] G. Matyas,et al. Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids. , 1991, Biochemical and biophysical research communications.
[34] G Blume,et al. Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.
[35] H. Lim. The complement system. Activation, modulation, and clinical relevance. , 1990, Dermatologic clinics.
[36] M. Cotten,et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Cotten,et al. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Mannik,et al. The location of binding sites on C1q for DNA. , 1990, Journal of immunology.
[39] T. Yokochi,et al. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action. , 1990, Journal of immunology.
[40] James M. Wilson,et al. Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. , 1989, The Journal of biological chemistry.
[41] J. Behr,et al. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[42] B. Meyrick,et al. Expression of a prokaryotic gene in cultured lung endothelial cells after lipofection with a plasmid vector. , 1989, American journal of respiratory cell and molecular biology.
[43] C. Wu,et al. Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.
[44] R. Dwek,et al. Interaction of Clq with DNA , 1982 .
[45] H. Gewurz,et al. Complement activation by interaction of polyanions and polycations. , 1975, Immunology.
[46] R. Winchester,et al. Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. , 1970, Immunology.
[47] K. Mechtler,et al. COMPLEMENT ACTIVATION BY POLYLYSINE-DNA COMPLEXES , 1996 .
[48] M. Hashida,et al. In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. , 1995, Journal of drug targeting.
[49] N. Cooper. The classical complement pathway: activation and regulation of the first complement component. , 1985, Advances in immunology.
[50] James R. Dewald,et al. A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .
[51] H. van Dijk,et al. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. , 1983, Journal of immunological methods.